Advanced search
Publication Cover
Fetal and Pediatric Pathology Volume 34, 2015 - Issue 3
Submit an article Journal homepage
6,104
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Quantification of Sickle Cells in the Peripheral Smear as a Marker of Disease Severity

Ofelia AlvarezDepartment of Pediatrics, Mailman Center Child Development, University of Miami, Miami, Florida, USA
,
Naomi S. MontagueDepartment of Pathology, Holtz Children's Hospital, University of Miami, Miami, Florida, USA
,
Marta MarinDepartment of Pathology, Jackson Memorial Hospital, Miami, Florida, USA
,
Robert O'BrienDepartment of Epidemiology & Public Health, Clinical Research Building, University of Miami, Miami, Florida, USA
&
Maria Matilde RodriguezDepartment of Pathology, Holtz Children's Hospital, University of Miami, Miami, Florida, USACorrespondence[email protected]
Pages 149-154 | Received 09 Nov 2014, Accepted 11 Nov 2014, Published online: 17 Dec 2014

REFERENCES

  • Charache S, Barton FB, Moore RD, et al. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive “switching” agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) 1996;75:300–302.
  • Rodgers GP, Noguchi CT, Schechter AN. Irreversible sickled erythrocytes in sickle cell anemia: a quantitative reappraisal. Am J Hematol 1985;20:17–23.
  • Clark MR, Mohandas N, Embury SH, Lubin BH. A simple laboratory alterative to irreversible sickled cells (ISC) counts. Blood 1982;60:659–662.
  • Serjeant GR, Serjeant BE. Sickle Cell Disease. 3rd edn. Oxford University Press, 2001.
  • Jensen WN, Rucknage DL, Taylor WJ. In vivo study of the sickle cell phenomenon. J Clin Med 1960;56:854–865.
  • Brown AK, Sleeper LA, Miller ST, et al. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease. Arch Pediatr Adolesc Med 1994;148:796–804.
  • Barreras L, Diggs LW. Bicarbonates, pH, and percentage of sickle cells in venous blood in patients with sickle cell crisis. Am J Med Sci 1964;247:710–718.
  • Zipursky A, Chachula DM, Brown EJ. The reversibly sickled cell. Am J Pediatr Hematol Oncol 1993;15:219–225.
  • Asakura T, Asakura K, Obata K, et al. Blood samples collected under venous pressure from patients with sickle cell disease contain a significant number of a new type of reversibly sickled cells: Constancy of the percentage of sickled cells in individual patients during steady state. Am J Hematol 2005;80:249–256.
  • Smith CM 2nd, Krivit W, White JG. The irreversibly sickled cell. Am J Pediatr Hematol Oncol 1982;4:307–315.
  • Steinberg MH, Dreiling BJ, Lovell WJ. Sickle cell anemia: Erythrokinetics, blood volumes, and a study of possible determinants of severity. Am J Hematol 1977;2:17–23.
  • Hebbel RB, Boogarerts MAB, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle cell anemia. N Engl J Med 1980;302:992–995.
  • Wang WC, Ware RE, Miller ST, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet 2011;377:1663–1672.
  • Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev 2007;21:37–47.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.